EURORAD ESR

Case 1149

Malignant superior vena cava syndrome. Treatment with stent placement

Author(s)
A.Hatzidakis, A.Athanasiou, T.G.Maris, G.Kochiadakis, N.Gourtsoyiannis
 
Patient
male, 64 year(s)
 
 
  • Published 13.07.2001
  • DOI 10.1594/EURORAD/CASE.1149
  • Section Cardiovascular
  • Case Type Clinical Cases
  • Difficulty Resident
  • Views 10581
  • Language(s)
  • Figure 1
    Chest-CT

    Chest computed tomography at the level of superior vena cava after i.v. injection of contrast medium. A hypodense mass of the right upper hilum is seen posterior to the superior vena cava. The mass is embracing the...

     
    Area of Interest: unknown; Imaging Technique: Chest-CT;
     
     
  • Figure 2
    Chest-X-Ray

    Posteroanterior chest x-ray reveales right upper lobe atelectasis with co-existing pleural effusion.

     
    Area of Interest: unknown; Imaging Technique: Chest-X-Ray;
     
     
  • Figure 3
    Superior vena cava phlebography

    Right transjugular venography of the superior vena cava (SVC) shows a huge filling defect in the dilated SVC due to tumor infiltration.

     
    Area of Interest: unknown; Imaging Technique: Superior vena cava phlebography;
     
     
  • Figure 4
    Stent placement
     

    A 9 cm long and 20 mm wide Wallstent is inserted in the SVC.

     
    Area of Interest: unknown; Imaging Technique: Stent placement;

    A patent SVC is opacified after expansion of the metallic stent. The obstructing mass is laterally displaced.

     
    Area of Interest: unknown; Imaging Technique: Stent placement;
     
     
Chest computed tomography at the level of superior vena cava after i.v. injection of contrast medium. A hypodense mass of the right upper hilum is seen posterior to the superior vena cava. The mass is embracing the vein without obstructing it.
 
Posteroanterior chest x-ray reveales right upper lobe atelectasis with co-existing pleural effusion.
 
Right transjugular venography of the superior vena cava (SVC) shows a huge filling defect in the dilated SVC due to tumor infiltration.
 
A 9 cm long and 20 mm wide Wallstent is inserted in the SVC.
 
A patent SVC is opacified after expansion of the metallic stent. The obstructing mass is laterally displaced.
 
 
 
Home Search Sections Teaching Cases History FAQ Case Archives Contact Login Disclaimer Imprint Switch to MOBILE version
View desktop version